Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 74126 - 74150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	THBS1	7057	downregulated	Silver results in decreased expression of THBS1 mRNA	15q14	A24216
Silver	Approved Investigational	TLR3	7098	upregulated	Silver analog results in increased expression of TLR3 mRNA	4q35.1	A24225
Silver	Approved Investigational	TLR3	7098	downregulated	Silver results in decreased expression of TLR3 mRNA	4q35.1	A24217
Silver	Approved Investigational	TLR6	10333	upregulated	Silver results in increased expression of TLR6 mRNA	4p14	A24217
Silver	Approved Investigational	TNF	7124	upregulated	Silver analog results in increased expression of TNF mRNA	6p21.33	A24224
Silver	Approved Investigational	TNFSF10	8743	downregulated	Silver analog results in decreased expression of TNFSF10 mRNA	3q26	A24225
Silver	Approved Investigational	TNFSF14	8740	upregulated	Silver analog results in increased expression of TNFSF14 mRNA	19p13.3	A24225
Silver	Approved Investigational	TOLLIP	54472	upregulated	Silver results in increased expression of TOLLIP mRNA	11p15.5	A24217
Silver	Approved Investigational	TPO	7173	upregulated	Silver analog results in increased expression of TPO mRNA	2p25.3	A24222
Silver	Approved Investigational	TRAF6	7189	upregulated	Silver results in increased expression of TRAF6 mRNA	11p12	A24217
Silver	Approved Investigational	TRIB3	57761	upregulated	Silver analog results in increased expression of TRIB3 mRNA	20p13	A24215
Silver	Approved Investigational	TXNRD1	7296	upregulated	Silver results in increased expression of TXNRD1 mRNA	12q23.3	A24218
Silver	Approved Investigational	UBR2	23304	upregulated	Silver results in increased expression of UBR2 mRNA	6p21.1	A24216
Silver	Approved Investigational	VCAN	1462	downregulated	Silver results in decreased expression of VCAN mRNA	5q14.2-q14.3	A24216
Silver	Approved Investigational	VEGFA	7422	upregulated	Silver results in increased expression of VEGFA mRNA	6p21.1	A24216
Silver	Approved Investigational	VIP	7432	upregulated	Silver results in increased expression of VIP mRNA	6q25.2	A24216
Silver	Approved Investigational	WNT7B	7477	downregulated	Silver results in decreased expression of WNT7B mRNA	22q13.31	A24216
Silver	Approved Investigational	ZEB1	6935	upregulated	Silver results in increased expression of ZEB1 mRNA	10p11.22	A24216
Silver	Approved Investigational	ZEB2	9839	downregulated	Silver results in decreased expression of ZEB2 mRNA	2q22.3	A24216
Silver	Approved Investigational	ZIC1	7545	downregulated	Silver results in decreased expression of ZIC1 mRNA	3q24	A24216
Silver	Approved Investigational	ZIC3	7547	downregulated	Silver results in decreased expression of ZIC3 mRNA	Xq26.3	A24216
Silver	Approved Investigational	ZIC4	84107	downregulated	Silver results in decreased expression of ZIC4 mRNA	3q24	A24216
Silver nitrate	Approved	ATM	472	upregulated	Silver Nitrate analog results in increased expression of ATM mRNA	11q22.3	A24229
Silver nitrate	Approved	ATR	545	upregulated	Silver Nitrate analog results in increased expression of ATR mRNA	3q23	A24229
Silver nitrate	Approved	BUB1	699	upregulated	Silver Nitrate analog results in increased expression of BUB1 mRNA	2q13	A24229

Displaying entries 74126 - 74150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability